DNA isolated from cells infected with FSFV (a foamy virus) is infectious when tested on susceptible cells. The virus produced by this infectious DNA is identical to the original infecting virus in terms of plaque and virion morphology and serology.
Short communications (a)
Transfection assays were performed using the calcium phosphate precipitation technique developed by Graham & van der Eb (I973) both with and without the modification of Stow & Wilkie 0976). Twenty #g of DNA, treated as in Table I , was diluted into HEPES buffered saline (HeBS, 2omM-HEPES; BDH Chemicals), I4omM-NaC1, 5mM-KC1, o'5 mM-Na2HPO4, 6 mM-glucose, pH 7"o) and z M-calcium chloride added to a final concentration of I3o mM, and a final volume of 8oo #1. Two hundred #1 of this solution (equivalent to 5 #g of DNA) was placed on to each of 4 sub-confluent monolayers in 5o mm Petri dishes seeded 48 h previously with o'33 × Io 6 FEA cells. After 4 ° min at 37 °C Eagle's MEM supplemented with 2 ~ foetal calf serum was added, and the incubation continued for 3 h 2o min at 37 °C. These timings are those optimal for the infectivity of HSV-I DNA (Stow & Wilkie, I976) . In the experiments employing calcium phosphate precipitation techniques alone, the monolayers were washed twice with Eagle's MEM before the addition of fresh EFCIo and incubation at 37 °C. When the modification of Stow & Wilkie (I976) was employed I ml of I5 ~o dimethyl sulphoxide (DMSO) in HeBS was added to each dish after the first wash. After 4 min at room temperature the DMSO was removed and the monolayers washed once with Eagle's MEM before the addition of EFCIo and incubated at 37 °C. After one day the medium was replaced with fresh EFCIo. After 5 days at 37 °C the plates were stained with Giemsa and the number of plaques scored. In the experiments using virus (see Table I b) the treatment of the cells was identical except the DNA was replaced with 2"4 × Io 3 p.f.u, of FSFV.
DNA was treated with restriction endonucleases Hind III, Bgl II and Xba (Table I ) using the methods described by Wilkie & Cortini (I976) .
Monolayers to be used for electron microscopy were fixed in 2"5 ~ glutaraldehyde when Short communications 553 c.p.e, involved 60 700 of cells. Post-fixation was in I ~oo osmium tetroxide for 30 min at room temperature. Dehydration was performed in a graded series of alcohols and cells were embedded in araldite resin. Ultrathin sections were strained with uranyl acetate and lead citrate. Table I shows the effects of various treatments on the infectivity of DNA isolated from infected cells, and compares these effects with the effect some of the treatments have on the infectivity of FSFV. The results show that although DNA extracted from uninfected FEA cells does not produce any plaques, DNA extracted from FEA cells infected with FSFV produces an average of 42.5 syncytial plaques per 5 #g of DNA. It also shows that the postinfection treatment of the monolayer with t5 ~ DMSO increased the sensitivity of the assay five-to tenfold. The infectivity of this DNA is sensitive to DNase and sonication (sonication under these conditions reduced the size of DNA to < o'5 × Io s daltons; our unpublished observations) but insensitive to RNase and protease (Table I a-the reduction in the number of plaques after protease treatment is probably due to the effect of the protease on the cell monolayer). This is in contrast to the infectivity of FSFV which is sensitive to protease but insensitive to sonication (Table I b). We conclude from these results, along with the sensitivity of the infectious DNA to restriction endonucleases Hind III, Bgl II and Xba (Table I a), that the infectious material is DNA.
The morphology of the plaques produced by the infectious DNA is identical with those produced after infection of FEA monolayers with FSFV (Fig. I a) . To confirm that the virus produced by the transfection process is identical to the original FSFV used in the lytic infection, we used two additional criteria: (a) morphology of the virion in infected cells; (b) sensitivity of the infectious agent obtained from monolayers infected with DNA to FSFV specific antiserum. The FSFV antiserum, generously provided by Dr O. Jarrett, consisted of pooled serum from infected cats. Incubation of the infectious agent produced from monolayers infected with FSFVinfected cell DNA with a II25 dilution of FSFV specific antiserum reduced the infectivity from 7"75 x lO 3 p.f.u./ml to < 5 x IO ° p.f.u./ml. Similarly, the yield from monolayers infected with FSFV was reduced in infectivity from 5"2 x IO a p.f.u./ml to < 5 x IO ° p.f.u./ml.
Thus, DNA was extracted from cells infected with FSFV, which upon transfection produced morphologically and serologically identical virus to the original infecting FSF virus. Preliminary results using the Hirt extraction procedure (Hirt, I967) indicate that at least some of this proviral DNA is integrated into the host cell genome (our unpublished data). Members of all three sub-families of the Retroviridae have now been shown to replicate through a DNA proviral stage. These findings substantiate the inclusion of the Spumavirinae in the Retroviridae and show that the presence of reverse transcriptase is associated with transcription of the RNA virus genome into a DNA form even in lytic infections.
These results also confirm that the enhancement of DNA infectivity obtained by treating the cells with DMSO 4 h post-infection (Stow & Wilkie, I976) applies to several different virus DNA systems. The phenomenon has now been observed with infectious DNA isolated from cells infected with FSFV, as well as with the infectious virion nucleic acids of HSV-I (Stow & Wilkie, I976) and adenovirus-5 (E. Frost and J. Williams, unpublished data).
From dose-response experiments, specific infectivities of up to 50 plaques per/zg of DNA have been obtained with this assay (D. J. Chiswell & C. R. Pringle, in preparation). The fact that this is higher than that reported for visna virus (Haase et al. 1976 ) and avian tumour viruses (Cooper & Temin, I974) is probably a result of the increased efficiency of the transfection assay due to the DMSO treatment. We are now using this assay to investigate the genome structure of FSFV and the relationship between the proviral DNA and the host cell genome. Preliminary estimates of genome size indicate one of not more than IO × IO 6 daltons, and experiments are in progress to obtain a more accurate estimate of size, along with information on the kinetics of the dose-response relationship and the infectivity of denatured DNA (D. J. Chiswell & C. R. Pringle, in preparation).
